| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 57,8 k € | -24.6% | 76,6 k € | +16.4% | 65,8 k € | +17.7% | 55,9 k € | -26.2% | 75,8 k € | +85.4% | 40,9 k € | +14.4% | 35,7 k € | -44.4% | 64,3 k € | -13.6% | 74,4 k € | -34.4% | 113,5 k € | +74.5% | 65,0 k € | -15.2% | 76,7 k € | +90.8% | 40,2 k € | -53.0% | 85,5 k € | +3.1% | 82,9 k € | +190.1% | 28,6 k € | +357.8% | 6,2 k € | +135.7% | -17,5 k € | |
| EBITDA | 54,6 k € | -25.6% | 73,3 k € | +17.5% | 62,4 k € | +16.6% | 53,5 k € | -27.0% | 73,3 k € | +153.2% | 29,0 k € | +40.1% | 20,7 k € | -62.7% | 55,4 k € | -9.7% | 61,4 k € | -34.5% | 93,6 k € | +254.6% | 26,4 k € | -46.7% | 49,5 k € | +140.7% | 20,6 k € | -68.7% | 65,7 k € | -0.9% | 66,3 k € | +157.2% | 25,8 k € | +475.2% | 4,5 k € | +122.5% | -20,0 k € | |
| Operating profit | 29,7 k € | -38.7% | 48,4 k € | +28.9% | 37,6 k € | +25.3% | 30,0 k € | -40.5% | 50,4 k € | +1510.9% | 3,1 k € | +126.0% | -12,0 k € | -149.8% | 24,2 k € | +9.2% | 22,2 k € | -58.5% | 53,4 k € | +509.0% | -13,1 k € | -304.7% | 6,4 k € | +128.4% | -22,4 k € | -212.6% | 19,9 k € | -15.5% | 23,6 k € | +240.1% | -16,8 k € | -47.4% | -11,4 k € | +69.2% | -37,1 k € | |
| Profit/loss | 11,1 k € | -55.7% | 25,1 k € | +132.9% | 10,8 k € | +56.8% | 6,9 k € | -77.3% | 30,3 k € | +3.2% | 29,4 k € | +175.7% | -38,8 k € | -1714.7% | -2,1 k € | +62.6% | -5,7 k € | -121.8% | 26,3 k € | +169.7% | -37,7 k € | -67.6% | -22,5 k € | +60.2% | -56,5 k € | -267.5% | -15,4 k € | -17.1% | -13,1 k € | +78.9% | -62,1 k € | -307.8% | -15,2 k € | +67.2% | -46,5 k € | |
| Equity | -31,5 k € | +26.1% | -42,6 k € | +37.0% | -67,6 k € | +13.7% | -78,4 k € | +8.0% | -85,3 k € | +53.0% | -181,4 k € | +13.9% | -210,7 k € | -22.6% | -172,0 k € | -1.3% | -169,8 k € | -3.5% | -164,1 k € | +13.8% | -190,4 k € | -24.7% | -152,7 k € | -17.3% | -130,2 k € | -76.6% | -73,7 k € | -26.3% | -58,3 k € | -29.0% | -45,2 k € | -4.9% | -43,1 k € | -54.6% | -27,9 k € | |
| Total assets | 335,1 k € | -10.2% | 373,0 k € | -5.9% | 396,2 k € | -2.5% | 406,5 k € | -5.1% | 428,4 k € | -12.2% | 488,1 k € | -9.0% | 536,2 k € | -1.7% | 545,5 k € | -4.0% | 568,4 k € | -7.1% | 611,8 k € | -8.8% | 670,4 k € | -5.9% | 712,4 k € | -3.4% | 737,4 k € | -3.0% | 760,4 k € | +0.6% | 755,9 k € | -6.0% | 803,9 k € | +42.9% | 562,7 k € | +360.8% | 122,1 k € | |
| Cash | 4,9 k € | -47.3% | 9,3 k € | +60.9% | 5,7 k € | -6.6% | 6,2 k € | -21.1% | 7,8 k € | +11.2% | 7,0 k € | -35.9% | 10,9 k € | +39.9% | 7,8 k € | -16.0% | 9,3 k € | -21.0% | 11,8 k € | -48.3% | 22,8 k € | -0.0% | 22,8 k € | +33.8% | 17,0 k € | +3.9% | 16,4 k € | +138.2% | 6,9 k € | +71.8% | 4,0 k € | -53.6% | 8,6 k € | +547.4% | 1,3 k € | |
| Debts | 364,5 k € | -11.7% | 412,8 k € | -10.3% | 460,2 k € | -5.1% | 484,9 k € | -5.6% | 513,6 k € | -23.1% | 667,5 k € | -10.4% | 745,2 k € | +4.1% | 716,1 k € | -2.7% | 735,8 k € | -4.7% | 772,3 k € | -9.4% | 852,5 k € | -1.4% | 865,1 k € | -0.3% | 867,6 k € | +4.0% | 834,1 k € | +2.4% | 814,2 k € | -4.1% | 849,2 k € | +40.2% | 605,8 k € | +303.9% | 150,0 k € | |
| Staff | — | — | — | — | — | — | — | — | 0,3 | 0,4 | 0,8 | 0,8 | 0,5 | 0,5 | 0,4 | — | — | — | ||||||||||||||||||
Private limited company · Waregem · incorporated on 15/11/2005
Private limited company with a balanced profile. Cash position declining (-47.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DIERENARTSENPRAKTIJK DROGENBOOM is a Private limited company incorporated in 2005. Its main activity is: Veterinary activities. Its registered office is in Waregem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette